Chengdu Kanghua Biological Products (300841) - Total Liabilities

Latest as of September 2025: CN¥430.82 Million CNY ≈ $63.04 Million USD

Based on the latest financial reports, Chengdu Kanghua Biological Products (300841) has total liabilities worth CN¥430.82 Million CNY (≈ $63.04 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 300841 asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Chengdu Kanghua Biological Products - Total Liabilities Trend (2015–2024)

This chart illustrates how Chengdu Kanghua Biological Products's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Chengdu Kanghua Biological Products (300841) total assets.

Chengdu Kanghua Biological Products Competitors by Total Liabilities

The table below lists competitors of Chengdu Kanghua Biological Products ranked by their total liabilities.

Company	Country	Total Liabilities
Smarter Microelectronics (Guangzhou) Co. Ltd. A SHG:688512	China	CN¥405.52 Million
Shenzhen Sunshine Laser & Electronics Technology Co Ltd SHE:300227	China	CN¥2.93 Billion
Jolywood Suzhou Sunwatt Co Ltd SHE:300393	China	CN¥12.43 Billion
Guangdong Silvere Sci and Tech SHE:300221	China	CN¥893.52 Million
Amphastar P NASDAQ:AMPH	USA	$975.61 Million
Amerant Bancorp Inc. NYSE:AMTB	USA	$8.84 Billion
Ficont Industry (Beijing) Co. Ltd. SHG:605305	China	CN¥664.38 Million
Shunfa Hengye Corp SHE:000631	China	CN¥1.72 Billion

Liability Composition Analysis (2015–2024)

This chart breaks down Chengdu Kanghua Biological Products's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See debt-free asset ratio of Chengdu Kanghua Biological Products to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	5.85	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.12	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.11	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Chengdu Kanghua Biological Products's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Chengdu Kanghua Biological Products (2015–2024)

The table below shows the annual total liabilities of Chengdu Kanghua Biological Products from 2015 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥580.07 Million ≈ $84.88 Million	-16.56%
2023-12-31	CN¥695.22 Million ≈ $101.73 Million	+9.41%
2022-12-31	CN¥635.40 Million ≈ $92.98 Million	+82.72%
2021-12-31	CN¥347.74 Million ≈ $50.89 Million	+100.72%
2020-12-31	CN¥173.24 Million ≈ $25.35 Million	+51.32%
2019-12-31	CN¥114.49 Million ≈ $16.75 Million	-3.29%
2018-12-31	CN¥118.37 Million ≈ $17.32 Million	+37.05%
2017-12-31	CN¥86.38 Million ≈ $12.64 Million	-70.94%
2016-12-31	CN¥297.23 Million ≈ $43.49 Million	+9.03%
2015-12-31	CN¥272.61 Million ≈ $39.89 Million	--

About Chengdu Kanghua Biological Products

SHE:300841 China Biotechnology

Market Cap

$980.24 Million

CN¥6.70 Billion CNY

Market Cap Rank

#9049 Global

#2232 in China

Share Price

CN¥51.55

Change (1 day)

+2.59%

52-Week Range

CN¥42.86 - CN¥84.21

All Time High

CN¥399.08